1 Min Read
Oct 19 (Reuters) - Imprimis Pharmaceuticals Inc
* CEO - Intends to start selling prescriptions for its cheaper alternative to Restasis on November 1 Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.